Evidence map›Paper›PMID 28222680›Full record

ArticleBMC infectious diseases2017

Field evaluation of a recombinase polymerase amplification assay for the diagnosis of Schistosoma japonicum infection in Hunan province of China.

Weiwei Xing, Xinling Yu, Jingtao Feng, Kui Sun, Wenliang Fu, Yuanyuan Wang, Minji Zou, Wenrong Xia, Zhihong Luo, Hongbin He and 2 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. A mini review on advances in diagnostic techniques forFrontiers in veterinary science · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Schistosomiasis with a Focus on Africa.Tropical medicine and infectious disease · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Weiwei XingThe Laboratory of genomic engineering, Beijing Institute of Basic Medical Sciences, Beijing, China.
Xinling YuThe key laboratory of Immune and Control of Schistosomiasis, Hunan Institute of Parasitic Diseases, Hunan, China.
Jingtao FengThe key laboratory of Immune and Control of Schistosomiasis, Hunan Institute of Parasitic Diseases, Hunan, China.
Kui SunThe Laboratory of genomic engineering, Beijing Institute of Basic Medical Sciences, Beijing, China.
Wenliang FuThe Laboratory of genomic engineering, Beijing Institute of Basic Medical Sciences, Beijing, China.
Yuanyuan WangThe Laboratory of genomic engineering, Beijing Institute of Basic Medical Sciences, Beijing, China.
Minji ZouThe Laboratory of genomic engineering, Beijing Institute of Basic Medical Sciences, Beijing, China.
Wenrong XiaThe Laboratory of genomic engineering, Beijing Institute of Basic Medical Sciences, Beijing, China.
Zhihong LuoThe key laboratory of Immune and Control of Schistosomiasis, Hunan Institute of Parasitic Diseases, Hunan, China.
Hongbin HeThe key laboratory of Immune and Control of Schistosomiasis, Hunan Institute of Parasitic Diseases, Hunan, China.
Yuesheng LiQueensland Institute of Medical Research, Brisbane, Australia.
Donggang XuThe Laboratory of genomic engineering, Beijing Institute of Basic Medical Sciences, Beijing, China. xudg@bmi.ac.cn.
Institute of Basic Medical Sciences of the Chinese Academy of Medical SciencesJiangsu Institute of Parasitic Diseases · CNQIMR Berghofer Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent diagnostic methods for Schistosoma japonicum infection are insensitive for low-density infections. Therefore, a new diagnostic assay based on recombinase polymerase amplification (RPA) technology was established and assessed for field applification.

methodsThe S.japonicum RPA assay was developed to target highly repetitive retrotransposon SjR2 gene of S japonicum, and its sensitivity and specificity were assessed by serial dilution of S. japonicum genomic DNA and other related worm genomic DNA respectively. The RPA diagnostic validity was first evaluated in 60 fecal samples from healthy people and patients, and then compared with other diagnostic tests in 200 high-risk individuals living in endemic areas.

resultsThe real time RPA assay could detect 0.9 fg S. japonicum DNA within 15 min and distinguish S. japonicum from other worms. The validity analysis of RPA for the detection of S. japonicum in stool samples from 30 S. japonicum-infected patients and 30 healthy persons indicated 100% sensitivity and specificity. When testing 200 fecal or serum samples from a high-risk population, the percentage sensitivity of RPA was 100%, whereas that of indirect hemagglutination assay (IHA) and enzyme-linked immunosorbent assay (ELISA) were 80.3% and 85.2% respectively. In addition, the RPA presented better consistency with the stool-based tests than IHA and ELISA. Overall, the RPA was superior to other detection methods with respect to detection time, sensitivity, and convenience.

conclusionsThis is the first time we applied the RPA technology to the field evaluation of S. japonicum infection. And the results suggest that RPA-based assays can be used as a promising point-of-care test for the diagnosis of schistosomiasis.

Indexed as

Point-of-Care SystemsAdolescentAdultAgedAnimalsCase-Control StudiesChinaDNA, HelminthEnzyme-Linked Immunosorbent AssayFemaleHemagglutination TestsHumansMaleMiddle AgedPolymerase Chain ReactionRecombinasesDNA, HelminthRecombinasesDiagnosisField evaluationRecombinase polymerase amplificationSchistosoma japonicum

Identifiers

PMID28222680
PMCPMC5320755
OpenAlexW2589825248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.